Drug class | Patients < 80 years | Patients ≥ 80 years | ||||
---|---|---|---|---|---|---|
Exposed patients | Prescriptions | Exposed patient days | Exposed patients | Prescriptions | Exposed patient days | |
All antibacterials | 5060 (100%a) | 172,963 (100%b) | 26,808 (100%a) | 725 (100%a) | 17,726 (100%b) | 2770 (100%a) |
All antibacterials except erythromycin | 4673 (92.4%) | 125,855 (72.8%) | 22,597 (84.3%) | 680 (93.8%) | 14,567 (82.2%) | 2477 (89.4%) |
Tetracyclines | 93 (1.8%) | 1098 (0.6%) | 631 (2.4%) | 6 (0.8%) | 67 (0.4%) | 37 (1.3%) |
Penicillins | 1349 (26.7%) | 63,655 (36.8%) | 5640 (21.0%) | 211 (29.1%) | 8741 (49.3%) | 806 (29.1%) |
Cephalosporines | 1711 (33.8%) | 10,901 (6.3%) | 6208 (23.2%) | 248 (34.2%) | 1041 (5.9%) | 689 (24.9%) |
Carbapenems | 890 (17.6%) | 14,973 (8.7%) | 5787 (21.6%) | 81 (11.2%) | 961 (5.4%) | 389 (14.0%) |
Macrolides | 1574 (31.1%) | 47,311 (27.4%) | 10,366 (38.7%) | 168 (23.2%) | 3183 (18.0%) | 734 (26.5%) |
Clarithromycin | 34 (0.7%) | 203 (0.1%) | 124 (0.5%) | 7 (1.0%) | 24 (0.1%) | 17 (0.6%) |
Lincosamides | 219 (4.3%) | 966 (0.6%) | 465 (1.7%) | 40 (5.5%) | 194 (1.1%) | 95 (3.4%) |
Aminoglycosides | 85 (1.7%) | 689 (0.4%) | 361 (1.3%) | 6 (0.8%) | 26 (0.1%) | 16 (0.6%) |
Fluoroquinolones | 1474 (29.1%) | 13,954 (8.1%) | 4950 (18.5%) | 198 (27.3%) | 1447 (8.2%) | 556 (20.1%) |
Glycopeptides | 88 (1.7%) | 473 (0.3%) | 297 (1.1%) | 9 (1.2%) | 28 (0.2%) | 17 (0.6%) |
Imidazoles | 1483 (29.3%) | 12,601 (7.3%) | 5297 (19.8%) | 230 (31.7%) | 1762 (9.9%) | 768 (27.7%) |
Oxazolidinones | 493 (9.7%) | 5771 (3.3%) | 3163 (11.8%) | 36 (5.0%) | 251 (1.4%) | 147 (5.3%) |